Clinical transplantationAdultFemaleHumansMaleMiddle Aged
Belatacept-Based Immunosuppression and Donor-Specific Antibodies in Lung Transplant: A Multi-Institutional Retrospective Study.
Moustafa Younis, Christopher I Mederos, Cecelia M Miller, Pooja Kumar, Ariana Ishaq, Amy Mu, Cynthia Gries, Victoria Reams, Mohammad A Aladaileh, Mindaugas Rackauskas, Vaidehi Kaza, Srinivas Bollineni, Fernando Torres, Amir Emtiazjoo, Irina Timofte
Published: 202510.1111/ctr.70415
Abstract
BACKGROUND: Belatacept use in renal transplant is associated with similar graft survival and elimination of preexisting donor-specific antibodies (DSA). We aim to describe the impact of Belatacept use on de novo DSA in lung transplant (LTx). METHODS:…
Preview only. Read the full abstract at the source